These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Renal Sympathetic Denervation: A Viable Option for Treating Resistant Hypertension. Schlaich MP Am J Hypertens; 2017 Sep; 30(9):847-856. PubMed ID: 28338871 [TBL] [Abstract][Full Text] [Related]
5. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Witkowski A; Prejbisz A; Florczak E; Kądziela J; Śliwiński P; Bieleń P; Michałowska I; Kabat M; Warchoł E; Januszewicz M; Narkiewicz K; Somers VK; Sobotka PA; Januszewicz A Hypertension; 2011 Oct; 58(4):559-65. PubMed ID: 21844482 [TBL] [Abstract][Full Text] [Related]
6. Beyond blood pressure: percutaneous renal denervation for the management of sympathetic hyperactivity and associated disease states. McArdle MJ; deGoma EM; Cohen DL; Townsend RR; Wilensky RL; Giri J J Am Heart Assoc; 2015 Mar; 4(3):e001415. PubMed ID: 25801757 [No Abstract] [Full Text] [Related]
7. Effects of renal sympathetic denervation on cardiac sympathetic activity and function in patients with therapy resistant hypertension. van Brussel PM; Eeftinck Schattenkerk DW; Dobrowolski LC; de Winter RJ; Reekers JA; Verberne HJ; Vogt L; van den Born BJ Int J Cardiol; 2016 Jan; 202():609-14. PubMed ID: 26447672 [TBL] [Abstract][Full Text] [Related]
8. Renal denervation in hypertension: Towards a true revival? Courand PY; Azizi M; Lantelme P Arch Cardiovasc Dis; 2018 Oct; 111(10):541-544. PubMed ID: 30219622 [No Abstract] [Full Text] [Related]
9. Treatment resistant hypertension and renal sympathetic denervation: drug adherence and the consolidation of blood pressure lowering effects. Kjeldsen SE; Os I; Mahfoud F EuroIntervention; 2013 May; 9 Suppl R():R7-9. PubMed ID: 23732159 [No Abstract] [Full Text] [Related]
12. [Radiofrequency sympathetic renal denervation: a new version of the old method of treatment resistant hypertension]. Shavarov AA; Maĭskov VV; Kobalava ZhD Kardiologiia; 2013; 53(1):72-8. PubMed ID: 23548354 [No Abstract] [Full Text] [Related]
14. Renal sympathetic denervation: hypertension therapy and beyond. Williams PD; Whitbourn R Expert Rev Med Devices; 2013 May; 10(3):329-38. PubMed ID: 23668705 [TBL] [Abstract][Full Text] [Related]
15. Renal denervation: should we still hang in there? Hao Y; Lu Z Int J Cardiol; 2014 Oct; 176(3):1255-6. PubMed ID: 25129307 [No Abstract] [Full Text] [Related]
17. Chronic kidney disease: role of sympathetic nervous system activation and potential benefits of renal denervation. Hering D; Esler MD; Schlaich MP EuroIntervention; 2013 May; 9 Suppl R():R127-35. PubMed ID: 23732145 [TBL] [Abstract][Full Text] [Related]
18. Renal denervation in the era of HTN-3. Comprehensive review and glimpse into the future. Silva JD; Costa M; Gersh BJ; Gonçalves L J Am Soc Hypertens; 2016 Aug; 10(8):656-70. PubMed ID: 27319336 [TBL] [Abstract][Full Text] [Related]
19. Modulation of Sympathetic Overactivity to Treat Resistant Hypertension. Voora R; Hinderliter AL Curr Hypertens Rep; 2018 Sep; 20(11):92. PubMed ID: 30194545 [TBL] [Abstract][Full Text] [Related]
20. Renal sympathetic denervation as antihypertensive therapy--a reappraisal of first results. Veelken R; Mann JF Nephrol Dial Transplant; 2013 Nov; 28(11):2698-701. PubMed ID: 23945992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]